Literature DB >> 16373870

The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis.

Hassan F Nadrous1, Patricia A Pellikka, Michael J Krowka, Karen L Swanson, Nithima Chaowalit, Paul A Decker, Jay H Ryu.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16373870     DOI： 10.1378/chest.128.6_suppl.616S-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  24 in total

Review 1.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

2.  Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.

Authors:  Misbah Baqir; Eunhee E Yi; Thomas V Colby; Christian W Cox; Jay H Ryu; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 4.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

Review 5.  Recipient selection process and listing for lung transplantation.

Authors:  Geert M Verleden; Lieven Dupont; Jonas Yserbyt; Veronique Schaevers; Dirk Van Raemdonck; Arne Neyrinck; Robin Vos
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 6.  Pulmonary hypertension associated with lung diseases and hypoxemia.

Authors:  Michael J Cuttica
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

7.  Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.

Authors:  Helen E Jo; Sharan Randhawa; Tamera J Corte; Yuben Moodley
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

8.  Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Authors:  R Saggar; D J Ross; R Saggar; D A Zisman; A Gregson; J P Lynch; M P Keane; S Samuel Weigt; A Ardehali; B Kubak; C Lai; D Elashoff; M C Fishbein; W D Wallace; J A Belperio
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

9.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Authors:  Laszlo Farkas; Daniela Farkas; Kjetil Ask; Antje Möller; Jack Gauldie; Peter Margetts; Mark Inman; Martin Kolb
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

10.  Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.

Authors:  Vinayak Shenoy; Altin Gjymishka; Yagna P Jarajapu; Yanfei Qi; Aqeela Afzal; Katya Rigatto; Anderson J Ferreira; Rodrigo A Fraga-Silva; Patrick Kearns; Jane Yellowlees Douglas; Deepmala Agarwal; Kamal K Mubarak; Chastity Bradford; William R Kennedy; Joo Y Jun; Anandharajan Rathinasabapathy; Erin Bruce; Dipankar Gupta; Arturo J Cardounel; J Mocco; Jawaharlal M Patel; Joseph Francis; Maria B Grant; Michael J Katovich; Mohan K Raizada
Journal:  Am J Respir Crit Care Med       Date:  2013-01-31       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.